Guiding Novel Neurologic Drug Approvals
The FDA’s review of drug and biological products in this medication class is critical, as a brain impairment impacts between 6.5% and 7.9% of adults in the United States.
Pain, Agitation, and Delirium: A Review of Pertinent Guideline Updates for Pharmacists
Treating pain can help decrease agitation, while limiting sedation can help prevent delirium within the ICU.
Alzheimer’s Disease: Current Treatments and Potential New Agents
Current research focuses on agents that target secretase enzymes to prevent plaque accumulation.
Copyright © 2000 - 2026 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.